{"id":"NCT00443846","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)","officialTitle":"An Open-label, Randomised, Comparative, Multi-centre Study of the Immunogenicity and Safety of the Concomitant Use of a Live Pentavalent Rotavirus Vaccine (RotaTeq®) and a Meningococcal Group C Conjugate (MCC) Vaccine in Healthy Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02-13","primaryCompletion":"2007-09-04","completion":"2007-10-23","firstPosted":"2007-03-06","resultsPosted":"2018-06-20","lastUpdate":"2018-06-20"},"enrollment":247,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningitis, Meningococcal","Rotavirus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"RotaTeq®","otherNames":["V260"]},{"type":"BIOLOGICAL","name":"NeisVac-C®","otherNames":[]}],"arms":[{"label":"Group 1: Concomitant Administration","type":"EXPERIMENTAL"},{"label":"Group 2: Sequential Administration","type":"ACTIVE_COMPARATOR"}],"summary":"Primary objective:\n\nTo check if RotaTeq® can be administered concomitantly with meningococcal Group C vaccine without impairing the efficacy of MCC vaccine. The hypothesis tested is that the seroprotection rate for MMC at 28 days after the second MCC vaccination with concomitant administration of RotaTeq® is non-inferior to that without non-concomitant (sequential) administration of RotaTeq®.","primaryOutcome":{"measure":"Percentage of Participants Achieving Seroresponse for Meningiococcal Group C Serotype","timeFrame":"28 days after the second dose of MCC vaccine (approximately 20 weeks)","effectByArm":[{"arm":"Group 1: Concomitant Administration","deltaMin":100,"sd":null},{"arm":"Group 2: Sequential Administration","deltaMin":100,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21389149"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":116},"commonTop":["Irritability","Diarrhoea","Pyrexia","Vomiting","Injection-site erythema"]}}